• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Mer酪氨酸激酶调节播散性前列腺癌细胞休眠。

Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular Dormancy.

作者信息

Cackowski Frank C, Eber Matthew R, Rhee James, Decker Ann M, Yumoto Kenji, Berry Janice E, Lee Eunsohl, Shiozawa Yusuke, Jung Younghun, Aguirre-Ghiso Julio A, Taichman Russell S

机构信息

Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, Michigan.

Division of Hematology and Oncology, Department of Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan.

出版信息

J Cell Biochem. 2017 Apr;118(4):891-902. doi: 10.1002/jcb.25768. Epub 2016 Nov 10.

DOI:10.1002/jcb.25768
PMID:27753136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5296338/
Abstract

Many prostate cancer (PCa) recurrences are thought to be due to reactivation of disseminated tumor cells (DTCs). We previously found a role of the TAM family of receptor tyrosine kinases TYRO3, AXL, and MERTK in PCa dormancy regulation. However, the mechanism and contributions of the individual TAM receptors is largely unknown. Knockdown of MERTK, but not AXL or TYRO3 by shRNA in PCa cells induced a decreased ratio of P-Erk1/2 to P-p38, increased expression of p27, NR2F1, SOX2, and NANOG, induced higher levels of histone H3K9me3 and H3K27me3, and induced a G1/G0 arrest, all of which are associated with dormancy. Similar effects were also observed with siRNA. Most importantly, knockdown of MERTK in PCa cells increased metastasis free survival in an intra-cardiac injection mouse xenograft model. MERTK knockdown also failed to inhibit PCa growth in vitro and subcutaneous growth in vivo, which suggests that MERTK has specificity for dormancy regulation or requires a signal from the PCa microenvironment. The effects of MERTK on the cell cycle and histone methylation were reversed by p38 inhibitor SB203580, which indicates the importance of MAP kinases for MERTK dormancy regulation. Overall, this study shows that MERTK stimulates PCa dormancy escape through a MAP kinase dependent mechanism, also involving p27, pluripotency transcription factors, and histone methylation. J. Cell. Biochem. 118: 891-902, 2017. © 2016 Wiley Periodicals, Inc.

摘要

许多前列腺癌(PCa)复发被认为是由于播散肿瘤细胞(DTCs)的重新激活所致。我们之前发现受体酪氨酸激酶TYRO3、AXL和MERTK的TAM家族在PCa休眠调节中发挥作用。然而,单个TAM受体的机制和作用在很大程度上尚不清楚。在PCa细胞中通过短发夹RNA(shRNA)敲低MERTK,但不敲低AXL或TYRO3,会导致P-Erk1/2与P-p38的比值降低、p27、NR2F1、SOX2和NANOG的表达增加、组蛋白H3K9me3和H3K27me3水平升高,并诱导G1/G0期阻滞,所有这些都与休眠相关。使用小干扰RNA(siRNA)也观察到了类似的效果。最重要的是,在心脏内注射小鼠异种移植模型中,PCa细胞中MERTK的敲低增加了无转移生存期。MERTK敲低在体外也未能抑制PCa生长,在体内也未能抑制皮下生长,这表明MERTK对休眠调节具有特异性,或者需要来自PCa微环境的信号。p38抑制剂SB203580可逆转MERTK对细胞周期和组蛋白甲基化的影响,这表明丝裂原活化蛋白激酶(MAP激酶)对MERTK休眠调节很重要。总体而言,本研究表明MERTK通过依赖MAP激酶的机制刺激PCa休眠逃逸,该机制还涉及p27、多能性转录因子和组蛋白甲基化。《细胞生物化学杂志》118: 891 - 902, 2017。© 2016威利期刊公司

相似文献

1
Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular Dormancy.Mer酪氨酸激酶调节播散性前列腺癌细胞休眠。
J Cell Biochem. 2017 Apr;118(4):891-902. doi: 10.1002/jcb.25768. Epub 2016 Nov 10.
2
Tyro3, Axl, and Mertk receptors differentially participate in platelet activation and thrombus formation.酪氨酸激酶受体 Tyro3、Axl 和 Mer 受体激酶(Mertk)受体在血小板激活和血栓形成中发挥不同的作用。
Cell Commun Signal. 2018 Dec 12;16(1):98. doi: 10.1186/s12964-018-0308-0.
3
MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme.MerTK抑制是多形性胶质母细胞瘤的一种新型治疗方法。
Oncotarget. 2014 Mar 15;5(5):1338-51. doi: 10.18632/oncotarget.1793.
4
Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity.Axl 和 Mertk 受体通过联合致癌信号和逃避宿主抗肿瘤免疫来共同促进乳腺癌的进展。
Cancer Res. 2021 Feb 1;81(3):698-712. doi: 10.1158/0008-5472.CAN-20-2066. Epub 2020 Nov 25.
5
TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma.TAM 家族受体激酶抑制逆转 MDSC 介导的抑制作用,并增强黑色素瘤的抗 PD-1 治疗。
Cancer Immunol Res. 2019 Oct;7(10):1672-1686. doi: 10.1158/2326-6066.CIR-19-0008. Epub 2019 Aug 26.
6
Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow.内源性生长停滞特异性蛋白6(GAS6)和Mer受体信号传导调节骨髓中的前列腺癌干细胞。
Oncotarget. 2016 May 3;7(18):25698-711. doi: 10.18632/oncotarget.8365.
7
MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents.MERTK 介导对 AXL 靶向药物的内在和适应性耐药。
Mol Cancer Ther. 2018 Nov;17(11):2297-2308. doi: 10.1158/1535-7163.MCT-17-1239. Epub 2018 Aug 9.
8
Receptor tyrosine kinases Tyro3, Axl, and Mertk differentially contribute to antibody-induced arthritis.受体酪氨酸激酶 Tyro3、Axl 和 Mertk 对抗体诱导的关节炎有不同的作用。
Cell Commun Signal. 2023 Aug 3;21(1):195. doi: 10.1186/s12964-023-01133-0.
9
AXL Is a Putative Tumor Suppressor and Dormancy Regulator in Prostate Cancer.AXL 是前列腺癌中的一个潜在肿瘤抑制因子和休眠调控因子。
Mol Cancer Res. 2019 Feb;17(2):356-369. doi: 10.1158/1541-7786.MCR-18-0718. Epub 2018 Oct 5.
10
Galectin-3 Stimulates Tyro3 Receptor Tyrosine Kinase and Erk Signalling, Cell Survival and Migration in Human Cancer Cells.半乳糖凝集素-3 可刺激酪氨酸 3 受体酪氨酸激酶和 Erk 信号转导、细胞存活和人类癌细胞迁移。
Biomolecules. 2020 Jul 11;10(7):1035. doi: 10.3390/biom10071035.

引用本文的文献

1
A Pilot Study of the Combination of 5-Azacitidine and All-trans Retinoic Acid in Biochemically Recurrent Prostate Cancer.5-氮杂胞苷与全反式维甲酸联合治疗生化复发前列腺癌的初步研究
medRxiv. 2025 Aug 12:2025.08.11.25333316. doi: 10.1101/2025.08.11.25333316.
2
Apoptotic cell-derived extracellular vesicles-MTA1 confer radioresistance in cervical cancer by inducing cellular dormancy.凋亡细胞衍生的细胞外囊泡-MTA1通过诱导细胞休眠赋予宫颈癌放射抗性。
J Transl Med. 2025 Mar 14;23(1):328. doi: 10.1186/s12967-025-06350-4.
3
Towards understanding cancer dormancy over strategic hitching up mechanisms to technologies.

本文引用的文献

1
Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow.Axl 对于 TGF-β2 诱导的前列腺癌细胞在骨髓中休眠是必需的。
Sci Rep. 2016 Nov 7;6:36520. doi: 10.1038/srep36520.
2
Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.富含半胱氨酸的酸性分泌蛋白(SPARC)介导前列腺癌在骨中的转移休眠。
J Biol Chem. 2016 Sep 9;291(37):19351-63. doi: 10.1074/jbc.M116.737379. Epub 2016 Jul 15.
3
Role of protein S in castration-resistant prostate cancer-like cells.
通过将战略搭便车机制与技术相结合来理解癌症休眠。
Mol Cancer. 2025 Feb 14;24(1):47. doi: 10.1186/s12943-025-02250-9.
4
Stemness regulation in prostate cancer: prostate cancer stem cells and targeted therapy.前列腺癌中的干性调控:前列腺癌干细胞与靶向治疗
Ann Med. 2025 Dec;57(1):2442067. doi: 10.1080/07853890.2024.2442067. Epub 2024 Dec 23.
5
Exosome-delivered NR2F1-AS1 and NR2F1 drive phenotypic transition from dormancy to proliferation in treatment-resistant prostate cancer via stabilizing hormonal receptors.外泌体传递的NR2F1-AS1和NR2F1通过稳定激素受体驱动耐药性前列腺癌从休眠向增殖的表型转变。
J Nanobiotechnology. 2024 Dec 18;22(1):761. doi: 10.1186/s12951-024-03025-y.
6
Role of Chemokines and Cytokines in Prostate Cancer Skeletal Metastasis.趋化因子和细胞因子在前列腺癌骨转移中的作用。
Curr Osteoporos Rep. 2024 Nov 25;23(1):3. doi: 10.1007/s11914-024-00897-9.
7
The Role of TAM Receptors in Bone.TAM 受体在骨中的作用。
Int J Mol Sci. 2023 Dec 23;25(1):233. doi: 10.3390/ijms25010233.
8
Tumor removal limits prostate cancer cell dissemination in bone and osteoblasts induce cancer cell dormancy through focal adhesion kinase.肿瘤切除限制了前列腺癌细胞在骨中的扩散,成骨细胞通过粘着斑激酶诱导癌细胞休眠。
J Exp Clin Cancer Res. 2023 Oct 11;42(1):264. doi: 10.1186/s13046-023-02849-0.
9
TAM family kinases as therapeutic targets at the interface of cancer and immunity.酪氨酸激酶家族作为癌症与免疫交叉领域的治疗靶点。
Nat Rev Clin Oncol. 2023 Nov;20(11):755-779. doi: 10.1038/s41571-023-00813-7. Epub 2023 Sep 4.
10
Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancer.靶向 MerTK 可减少前列腺癌中的细胞吞噬作用并增加抗肿瘤免疫浸润。
Med Oncol. 2023 Aug 29;40(10):284. doi: 10.1007/s12032-023-02153-z.
蛋白S在去势抵抗性前列腺癌细胞样细胞中的作用。
Endocr Relat Cancer. 2016 Aug;23(8):595-607. doi: 10.1530/ERC-16-0126. Epub 2016 Jun 24.
4
The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.骨髓微环境控制播散性前列腺癌的癌症干细胞表型。
Oncotarget. 2016 Jul 5;7(27):41217-41232. doi: 10.18632/oncotarget.9251.
5
Growth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G Arrest/S Phase Delay and Inhibition of Apoptosis During Chemotherapy in Bone Marrow.生长停滞特异性蛋白6(GAS6)通过在化疗期间使骨髓中的细胞周期停滞于G期/S期延迟并抑制细胞凋亡来促进前列腺癌存活。
J Cell Biochem. 2016 Dec;117(12):2815-2824. doi: 10.1002/jcb.25582. Epub 2016 Sep 26.
6
To wake up cancer stem cells, or to let them sleep, that is the question.唤醒癌症干细胞,还是让它们沉睡,这是个问题。
Cancer Sci. 2016 Jul;107(7):875-81. doi: 10.1111/cas.12958. Epub 2016 Jun 20.
7
Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow.内源性生长停滞特异性蛋白6(GAS6)和Mer受体信号传导调节骨髓中的前列腺癌干细胞。
Oncotarget. 2016 May 3;7(18):25698-711. doi: 10.18632/oncotarget.8365.
8
Functional screen identifies kinases driving prostate cancer visceral and bone metastasis.功能筛选鉴定出驱动前列腺癌内脏和骨转移的激酶。
Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):E172-81. doi: 10.1073/pnas.1521674112. Epub 2015 Nov 30.
9
NR2F1 controls tumour cell dormancy via SOX9- and RARβ-driven quiescence programmes.NR2F1通过SOX9和RARβ驱动的静止程序控制肿瘤细胞休眠。
Nat Commun. 2015 Jan 30;6:6170. doi: 10.1038/ncomms7170.
10
The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer.TAM 家族:磷脂酰丝氨酸感知受体酪氨酸激酶在癌症中的失常。
Nat Rev Cancer. 2014 Dec;14(12):769-85. doi: 10.1038/nrc3847.